Observational study / 2016
Sixty percent of cancer patients starting curative-intent chemotherapy used CAM, with 27% ingesting biologically active CAM that could interact with treatment.
Seventy-five patients with solid tumor malignancies attending a cancer care day unit were interviewed about their CAM use on the day of their first chemotherapy dose. Sixty percent of participants were using CAM at the start of chemotherapy, and 27% ingested biologically active CAM assessed as having the potential to interact with prescribed chemotherapy. CAM was used by 51% for supportive care and 28% to treat cancer. Furthermore, 13% were advised by a CAM advice-giver not to have chemotherapy, and 84% desired pre-treatment information on CAM safety.
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional interview study
- Who was studied
- 75 solid tumor malignancy patients receiving curative-intent chemotherapy
- What was measured
- Types, reasons, influences, and potential interactions of complementary and alternative medicine (CAM) use
THE PAPER
Complementary and alternative medicine use by patients receiving curative-intent chemotherapy.
Smith PJ, Clavarino AM, Long JE, Anstey CM, Steadman KJ. Asia Pac J Clin Oncol, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.